Differential effects of WRAP53 transcript variants on non-small cell lung cancer cell behaviors
暂无分享,去创建一个
Yuan Luo | Yan Zhu | C. Xie | Xueping Jiang | Wen-jie Sun | Y. Gong | Zhengrong Huang | Yanping Gao | Shuying Li | Rui Bai
[1] Davoud Farajzadeh,et al. Haplotype and linkage disequilibrium of TP53-WRAP53 locus in Iranian-Azeri women with breast cancer , 2019, PloS one.
[2] S. Fan,et al. Expression of WDR79 is associated with TP53 mutation and poor prognosis in surgically resected non-small cell lung cancer , 2019, Journal of Cancer.
[3] Wang-Yu Zhu,et al. Prognostic value of mutant p53, Ki-67, and TTF-1 and their correlation with EGFR mutation in patients with non-small cell lung cancer. , 2019, Histology and histopathology.
[4] I. Berindan‐Neagoe,et al. The Function of Non-Coding RNAs in Lung Cancer Tumorigenesis , 2019, Cancers.
[5] H. Chander,et al. Awakening the “guardian of genome”: reactivation of mutant p53 , 2018, Cancer Chemotherapy and Pharmacology.
[6] Dong Sun Kim,et al. Promoter methylation of Wrap53α, an antisense transcript of p53, is associated with the poor prognosis of patients with non-small cell lung cancer , 2018, Oncology letters.
[7] L. Ding,et al. Oncogenic Activity of Wrap53 in Human Colorectal Cancer In Vitro and in Nude Mouse Xenografts , 2018, Medical science monitor : international medical journal of experimental and clinical research.
[8] X. Jiao,et al. The prognostic value of TP53 and its correlation with EGFR mutation in advanced non-small cell lung cancer, an analysis based on cBioPortal data base. , 2018, Lung cancer.
[9] K. Wiman,et al. Correction: WRAP53 Is Essential for Cajal Body Formation and for Targeting the Survival of Motor Neuron Complex to Cajal Bodies , 2018, PLoS biology.
[10] B. P. Jain,et al. WD40 Repeat Proteins: Signalling Scaffold with Diverse Functions , 2018, The Protein Journal.
[11] H. Sabe,et al. p53-Dependent and -Independent Epithelial Integrity: Beyond miRNAs and Metabolic Fluctuations , 2018, Cancers.
[12] W. Xiong,et al. WDR79 mediates the proliferation of non‐small cell lung cancer cells by regulating the stability of UHRF1 , 2018, Journal of cellular and molecular medicine.
[13] Wenwei Hu,et al. Mutant p53 in Cancer: Accumulation, Gain-of-Function, and Therapy. , 2017, Journal of molecular biology.
[14] Chao Yang,et al. WDR79 promotes the proliferation of non-small cell lung cancer cells via USP7-mediated regulation of the Mdm2-p53 pathway , 2017, Cell Death & Disease.
[15] X. Hua,et al. Somatic Genomics and Clinical Features of Lung Adenocarcinoma: A Retrospective Study , 2016, PLoS medicine.
[16] Mao Ye,et al. Overexpression of WDR79 in non‐small cell lung cancer is linked to tumour progression , 2016, Journal of cellular and molecular medicine.
[17] M. Sallam,et al. Investigation of long noncoding RNAs expression profile as potential serum biomarkers in patients with hepatocellular carcinoma. , 2016, Translational research : the journal of laboratory and clinical medicine.
[18] C. Méndez-Vidal,et al. Wrap53, a Natural p53 Antisense Transcript Required for p53 Induction upon DNA Damage. , 2016, Molecular cell.
[19] K. Jirström,et al. Downregulation of the cancer susceptibility protein WRAP53β in epithelial ovarian cancer leads to defective DNA repair and poor clinical outcome , 2015, Cell Death and Disease.
[20] M. Farnebo,et al. On the road with WRAP53β: guardian of Cajal bodies and genome integrity , 2015, Front. Genet..
[21] K. Roberg,et al. Nuclear expression of WRAP53β is associated with a positive response to radiotherapy and improved overall survival in patients with head and neck squamous cell carcinoma. , 2015, Oral oncology.
[22] B. Zhivotovsky,et al. The scaffold protein WRAP53β orchestrates the ubiquitin response critical for DNA double-strand break repair , 2014, Genes & development.
[23] V. Montazeri,et al. Single-strand conformational polymorphism analysis of a common single nucleotide variation in WRAP53 gene, rs2287499, and evaluating its association in relation to breast cancer risk and prognosis among Iranian-Azeri population , 2014, Medical Oncology.
[24] Ping Zhang,et al. TCAB1: a potential target for diagnosis and therapy of head and neck carcinomas , 2014, Molecular Cancer.
[25] Xuhong Song,et al. Overexpression of WRAP53 Is Associated with Development and Progression of Esophageal Squamous Cell Carcinoma , 2014, PloS one.
[26] J. Bourdon,et al. Uncovering the role of p53 splice variants in human malignancy: a clinical perspective , 2013, OncoTargets and therapy.
[27] S. Kouhsari,et al. Overlapping region of p53/wrap53 transcripts: mutational analysis and sequence similarity with microRNA-4732-5p. , 2013, Asian Pacific journal of cancer prevention : APJCP.
[28] J. Lubiński,et al. Association of common WRAP 53 variant with ovarian cancer risk in the Polish population , 2012, Molecular Biology Reports.
[29] Yan Wang,et al. Long non-coding RNAs: versatile master regulators of gene expression and crucial players in cancer. , 2012, American journal of translational research.
[30] M. Dobbelstein,et al. Anthracyclines induce the accumulation of mutant p53 through E2F1-dependent and -independent mechanisms , 2011, Oncogene.
[31] S. Mahmoudi,et al. WRAP53 promotes cancer cell survival and is a potential target for cancer therapy , 2011, Cell Death and Disease.
[32] Jian Kang,et al. Cisplatin induces apoptosis via upregulating Wrap53 in U-2OS osteosarcoma cells. , 2011, Asian Pacific journal of cancer prevention : APJCP.
[33] T. Myers,et al. Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita. , 2011, Genes & development.
[34] A. Werner,et al. What are natural antisense transcripts good for? , 2010, Biochemical Society transactions.
[35] D. Green,et al. Cytoplasmic functions of the tumour suppressor p53 , 2009, Nature.
[36] J. Steitz,et al. A conserved WD40 protein binds the Cajal body localization signal of scaRNP particles. , 2009, Molecular cell.
[37] Timothy D. Veenstra,et al. A Human Telomerase Holoenzyme Protein Required for Cajal Body Localization and Telomere Synthesis , 2009, Science.
[38] Robert Welch,et al. Common genetic variation in TP53 and its flanking genes, WDR79 and ATP1B2, and susceptibility to breast cancer , 2007, International journal of cancer.
[39] J. Venables. Unbalanced alternative splicing and its significance in cancer , 2006, BioEssays : news and reviews in molecular, cellular and developmental biology.
[40] D. Black. Mechanisms of alternative pre-messenger RNA splicing. , 2003, Annual review of biochemistry.